Lyme Disease: New Research Offers Fresh Hope

Lyme disease

There is light at the end of the tunnel for Lyme disease sufferers according to a recent report release on the strength of a study “Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome” led by Dr. Steven E. Schutzer of the University of Medicine and Dentistry of New Jersey-New Jersey Medical School, and Dr. Thomas Angel, Dr. Tao Liu, and Dr. Richard D. Smith of the Pacific Northwest National Laboratory.

The study was published in the February 23rd issue of PLoS ONE and one person heaving a sigh of relief is Dr. Harriet Kotsoris, who is the Medical Director for Time for Lyme, a Connecticut based, non-profit organization which has raised raided $5 million funding between 2002 and date. He was quoted as saying “The potential for spinal fluid biomarker detection to aid or actually establish diagnosis of Lyme disease is within our grasp.”

He was speaking on the strength of the findings of the study which showed chronic fatigue syndrome patients, patients with persistent neurologic symptoms, Lyme disease patients and some healthy individuals possess different proteins in their cerebrospinal fluid (CSF).

The CSF findings were made through “protein profiling” of spinal fluid make at least one bold statement– Lyme disease is a separate entity on its own.

To further consolidate, Time for Lyme has slated a biannual fundraising gala, at the Hilton Stamford Hotel in Stamford, CT Illusions of Lyme, on April 2 at 6 p.m and proceeds from the event will be used to support research–tickets or more information available via calling 646-502-9374.